在缺血性中风后徒劳的再输液中,时间和组织窗口
Zhe Cheng1, Hongrui Wang2, Xiaokun Geng1,2,3
1Department of Neurology and the Stroke Intervention & Translational Center (SITC), Beijing Luhe Hospital, Capital Medical University, China.
Aging and disease
|November 5, 2024
概括
虚空的再注血,即恢复血液流动并不能使急性缺血性中风患者受益,仍然是一个挑战. 了解时间和组织窗口是提高再注射治疗成功的关键.
科学领域:
- 神经学 神经学
- 血管医学 血管医学
- 脑卒中研究 脑卒中研究
背景情况:
- 急性缺血性中风的治疗包括重灌策略,如血栓溶解和血栓切除术.
- 目前的再注血疗法只能在大约一半患有大血管封闭症的患者中实现功能独立.
- 虚无的再输血,即恢复血液流动未能使患者受益,是一个重要的临床问题.
研究的目的:
- 探索急性缺血性中风中徒劳的再输的复杂性.
- 突出时间和组织状况在确定再注血后中风结果中的关键作用.
- 通过更好地定义时间和组织窗口来讨论改进干预的策略.
主要方法:
- 这是一篇透视性的文章,综合了当前关于反注射策略和结果的知识.
- 作者回顾了导致无效再注血的因素,包括不可逆转的组织损伤和无回流现象.
- 分析重点是反时间,组织活力和临床益处之间的相互作用.
主要成果:
- 再输血的成功并不能保证,即使有及时的干预.
- 诸如再注血-未救援损伤,再注血引起的损伤和无回流现象等因素可以否定收益.
- 大脑组织的状况和再注射的时间显著影响患者的结果.
结论:
- 精确定义时间和组织窗口对于优化急性缺血性中风干预至关重要.
- 更好的理解可以带来量身定制的再注血机会,减少徒劳的再注血.
- 对这些窗口的进一步研究可能会扩大中风治疗的有效性,并改善患者的独立性.
相关概念视频
02:45Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
01:15Blood Transfusion
3.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460